254 related articles for article (PubMed ID: 33986840)
1. Therapeutic potential of interleukin-15 in cancer (Review).
Isvoranu G; Surcel M; Munteanu AN; Bratu OG; Ionita-Radu F; Neagu MT; Chiritoiu-Butnaru M
Exp Ther Med; 2021 Jul; 22(1):675. PubMed ID: 33986840
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-15 biology and its therapeutic implications in cancer.
Steel JC; Waldmann TA; Morris JC
Trends Pharmacol Sci; 2012 Jan; 33(1):35-41. PubMed ID: 22032984
[TBL] [Abstract][Full Text] [Related]
3. IL-15 in the Combination Immunotherapy of Cancer.
Waldmann TA; Dubois S; Miljkovic MD; Conlon KC
Front Immunol; 2020; 11():868. PubMed ID: 32508818
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of interleukin-21 in cancer.
Isvoranu G; Chiritoiu-Butnaru M
Front Immunol; 2024; 15():1369743. PubMed ID: 38638431
[TBL] [Abstract][Full Text] [Related]
5. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 21 treatment in a murine model as a novel potential cytokine immunotherapy for colon cancer.
Chen C; Liu X; Ren Y
Adv Clin Exp Med; 2018 May; 27(5):583-589. PubMed ID: 29616746
[TBL] [Abstract][Full Text] [Related]
8. Shaping of Natural Killer Cell Antitumor Activity by
Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
Front Immunol; 2017; 8():458. PubMed ID: 28491060
[TBL] [Abstract][Full Text] [Related]
9. Impact of IL-12 in Cancer.
Lu X
Curr Cancer Drug Targets; 2017; 17(8):682-697. PubMed ID: 28460617
[TBL] [Abstract][Full Text] [Related]
10. Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer.
Fewkes NM; Mackall CL
Cancer J; 2010; 16(4):392-8. PubMed ID: 20693852
[TBL] [Abstract][Full Text] [Related]
11. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
Törnroos H; Hägerstrand H; Lindqvist C
Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
[TBL] [Abstract][Full Text] [Related]
12. Bioengineering strategies to enhance the interleukin-18 bioactivity in the modern toolbox of cancer immunotherapy.
Taheri M; Tehrani HA; Daliri F; Alibolandi M; Soleimani M; Shoari A; Arefian E; Ramezani M
Cytokine Growth Factor Rev; 2024 Feb; 75():65-80. PubMed ID: 37813764
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model.
Berger A; Colpitts SJ; Seabrook MSS; Furlonger CL; Bendix MB; Moreau JM; McKillop WM; Medin JA; Paige CJ
J Immunother Cancer; 2019 Dec; 7(1):355. PubMed ID: 31856922
[TBL] [Abstract][Full Text] [Related]
14. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
15. Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP.
Fabbi M; Carbotti G; Ferrini S
J Leukoc Biol; 2015 Apr; 97(4):665-75. PubMed ID: 25548255
[TBL] [Abstract][Full Text] [Related]
16. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
17. The potential and promise of IL-15 in immuno-oncogenic therapies.
Robinson TO; Schluns KS
Immunol Lett; 2017 Oct; 190():159-168. PubMed ID: 28823521
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
Tahara H; Lotze MT
Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
[TBL] [Abstract][Full Text] [Related]
20. Common gamma chain cytokines in combinatorial immune strategies against cancer.
Pulliam SR; Uzhachenko RV; Adunyah SE; Shanker A
Immunol Lett; 2016 Jan; 169():61-72. PubMed ID: 26597610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
